Morpheus Data Case Studies Discovering new levels of agility with hybrid-cloud self-service and DevOps automation

Edit This Case Study Record

	Discovering new levels of agility with hybrid-cloud self-service and DevOps automation Morpheus Data

Discovering new levels of agility with hybrid-cloud self-service and DevOps automation

Morpheus Data

Technology Category	Infrastructure as a Service (IaaS) - Cloud Computing Infrastructure as a Service (IaaS) - Hybrid Cloud Infrastructure as a Service (IaaS) - Private Cloud Infrastructure as a Service (IaaS) - Public Cloud
Applicable Industries	Pharmaceuticals
Applicable Functions	Discrete Manufacturing Product Research & Development
Use Cases	Edge Computing & Edge Intelligence Predictive Maintenance
Services	Cloud Planning, Design & Implementation Services System Integration
Challenge	AstraZeneca’s Global Infrastructure Services (GIS) division acts as the centralized architecture and engineering team to support the huge volumes of IaaS and PaaS requests coming from seven key business units. Like most industries today, bio-pharmaceuticals is a segment where time is the enemy. Speed is the currency of competitive differentiation and as such the GIS leadership is under constant pressure to deliver more value in less time. After analyzing processes, the team determined that developer requests for resources took an average of 80 man-hours to fully deliver in a production ready state because of manual handoffs and approvals across systems and teams. The company was simply growing too quickly to continue with this type of bottleneck. The GIS team knew that unless they introduced additional automation and orchestration to streamline their processes, it could hinder future delivery times to their internal clients. Read More
About Customer	AstraZeneca is a global, science-led bio-pharmaceutical business that delivers innovative and life-changing medicines used by millions of patients worldwide. Operating in over 100 countries, with hundreds of projects in its pipeline at any given time, the company focuses on the discovery, development and commercialization of prescription medicines primarily for Oncology, Cardiovascular, Renal and Metabolism and Respiratory Therapy. AstraZeneca operates one of the most robust hybrid IT environments in the bio-pharmaceutical industry. Arguably one of the busiest and brightest in the business, the company’s enterprise IT organization oversees more than 16,000 virtual and physical servers and 2,700 applications across 15 global locations spanning on-prem VMware infrastructure and multiple public cloud providers including AWS, Microsoft Azure, and Google Cloud Platform. Read More
Solution	After realizing the legacy approach to VMware automation wasn’t cutting it, AstraZeneca decided to look for a more innovative and agnostic approach. The search led them to both traditional players and emerging technology vendors including Morpheus Data. During the Proof of Concept (PoC) phase, the results were immediate! Less than 24 hours after starting their implementation, the GIS team was able to enable push-button provisioning of new instances to their VMware ESX cluster using the Morpheus multi-cloud management platform. Once selecting Morpheus as their enabling technology for cloud automation, the global roll-out went very quickly across 8 data centers with thousands of applications under management. The increase in deployment speed not only enables AstraZeneca to compete more effectively in market, the GIS team has significantly reduced operational costs. Initially, Morpheus automatically orchestrated every IaaS and PaaS provisioning request through ServiceNow as the end-user facing interface. This included orchestrating across AstraZeneca’s compliance, networking, access, quality and control, operations and capacity management tools and platforms. With the agility gains seen through advanced hybrid-cloud automation, AstraZeneca has modernized their approach and is using the native Morpheus interface and APIs to move even faster while still assuring ServiceNow CMDB and other updates are happening in the background. Read More Log in to view content
Contents

Technology Category

Infrastructure as a Service (IaaS) - Cloud Computing

Infrastructure as a Service (IaaS) - Hybrid Cloud

Infrastructure as a Service (IaaS) - Private Cloud

Infrastructure as a Service (IaaS) - Public Cloud

Applicable Industries

Pharmaceuticals

Applicable Functions

Discrete Manufacturing

Product Research & Development

Use Cases

Edge Computing & Edge Intelligence

Predictive Maintenance

Services

Cloud Planning, Design & Implementation Services

System Integration

Challenge

AstraZeneca’s Global Infrastructure Services (GIS) division acts as the centralized architecture and engineering team to support the huge volumes of IaaS and PaaS requests coming from seven key business units. Like most industries today, bio-pharmaceuticals is a segment where time is the enemy. Speed is the currency of competitive differentiation and as such the GIS leadership is under constant pressure to deliver more value in less time. After analyzing processes, the team determined that developer requests for resources took an average of 80 man-hours to fully deliver in a production ready state because of manual handoffs and approvals across systems and teams. The company was simply growing too quickly to continue with this type of bottleneck. The GIS team knew that unless they introduced additional automation and orchestration to streamline their processes, it could hinder future delivery times to their internal clients.

About Customer

AstraZeneca is a global, science-led bio-pharmaceutical business that delivers innovative and life-changing medicines used by millions of patients worldwide. Operating in over 100 countries, with hundreds of projects in its pipeline at any given time, the company focuses on the discovery, development and commercialization of prescription medicines primarily for Oncology, Cardiovascular, Renal and Metabolism and Respiratory Therapy. AstraZeneca operates one of the most robust hybrid IT environments in the bio-pharmaceutical industry. Arguably one of the busiest and brightest in the business, the company’s enterprise IT organization oversees more than 16,000 virtual and physical servers and 2,700 applications across 15 global locations spanning on-prem VMware infrastructure and multiple public cloud providers including AWS, Microsoft Azure, and Google Cloud Platform.

Solution

After realizing the legacy approach to VMware automation wasn’t cutting it, AstraZeneca decided to look for a more innovative and agnostic approach. The search led them to both traditional players and emerging technology vendors including Morpheus Data. During the Proof of Concept (PoC) phase, the results were immediate! Less than 24 hours after starting their implementation, the GIS team was able to enable push-button provisioning of new instances to their VMware ESX cluster using the Morpheus multi-cloud management platform. Once selecting Morpheus as their enabling technology for cloud automation, the global roll-out went very quickly across 8 data centers with thousands of applications under management. The increase in deployment speed not only enables AstraZeneca to compete more effectively in market, the GIS team has significantly reduced operational costs. Initially, Morpheus automatically orchestrated every IaaS and PaaS provisioning request through ServiceNow as the end-user facing interface. This included orchestrating across AstraZeneca’s compliance, networking, access, quality and control, operations and capacity management tools and platforms. With the agility gains seen through advanced hybrid-cloud automation, AstraZeneca has modernized their approach and is using the native Morpheus interface and APIs to move even faster while still assuring ServiceNow CMDB and other updates are happening in the background.

Impact #1	Server and application builds went from a manual high-touch process to a fully automated and standardized workflow across on-premises and public clouds with the entire process taking less than 20 minutes.
Impact #2	Since implementation in 2017, AstraZeneca has focused on increased automation with the ultimate goal of ‘automating everything’. In an industry used to increasingly heightened regulatory compliance this has included, for example, automating build provisioning to ensure SOX and GxP compliance.
Impact #3	The move away from the ServiceNow Service Portal to the native Morpheus interface led to significantly decreased wait times, a reduction in shadow IT, and has saved costs through automation. Further adoption of the Morpheus persona-based interface will give additional non-technical users simple self-service IT.

Impact #1

Server and application builds went from a manual high-touch process to a fully automated and standardized workflow across on-premises and public clouds with the entire process taking less than 20 minutes.

Impact #2

Since implementation in 2017, AstraZeneca has focused on increased automation with the ultimate goal of ‘automating everything’. In an industry used to increasingly heightened regulatory compliance this has included, for example, automating build provisioning to ensure SOX and GxP compliance.

Impact #3

The move away from the ServiceNow Service Portal to the native Morpheus interface led to significantly decreased wait times, a reduction in shadow IT, and has saved costs through automation. Further adoption of the Morpheus persona-based interface will give additional non-technical users simple self-service IT.

Benefit #1	AstraZeneca saw initial savings in excess of $2.4M through reduced labor cost and reduction in delays through automation.
Benefit #2	In the three years since deployment the company has seen provisioning savings alone in excess of $6M.
Benefit #3	End-to-end deployment times improved by 177x with the orchestration automation capabilities of Morpheus.

Benefit #1

AstraZeneca saw initial savings in excess of $2.4M through reduced labor cost and reduction in delays through automation.

Benefit #2

In the three years since deployment the company has seen provisioning savings alone in excess of $6M.

Benefit #3

End-to-end deployment times improved by 177x with the orchestration automation capabilities of Morpheus.

Download PDF Version

Overview

Discovering new levels of agility with hybrid-cloud self-service and DevOps automation

Operational Impact

Quantitative Benefit